Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a517102b0f21068b1fc7cc0e59d0073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2eed5813cc91f82e76ae190ee97387fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61a14970b70c728909351a51f31c5c23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89495dcf9cd9bc2c70dec2bb00f192d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9827a8f36b663376d340a9b6bcc9231c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10122 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-92 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
filingDate |
1995-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88ec4859750a725916ad8ee5e3404a7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88471cb7772a88f02da3bb05dbe2ba8d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db56b1bfc636faa51db70eee8aab8eb1 |
publicationDate |
1996-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9617960-A2 |
titleOfInvention |
Methods for inhibiting the transcription-enhancing activity of the x protein of hepatitis b virus |
abstract |
The present invention provides high-throughput screening methods to identify inhibitors of Hepatitis B Virus (HBV) replication which act by inhibiting the ability of the pX protein of HBV to promote DNA binding of bZIP-containing transcription factors. The invention also provides methods for inhibiting replication of HBV by introducing into injected calls an inhibitor molecule that interferes with the binding of the pX protein to a bZIP domain in a bZIP-containing protein. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7001890-B1 |
priorityDate |
1994-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |